- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Bariatric surgery helps T2DM patients by reducing hepatic steatosis
Overview
In a new research, Kathrine Aglen Seeberg and colleagues have found that Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) were both extremely successful in decreasing hepatic steatosis, with an almost full clearance of liver fat 1 year after surgery. In the near term, bariatric surgery had less of an effect on the degree of fibrosis, but long-term progression must be assessed.
Losing weight helps with fatty liver disease. There has been no randomized investigation comparing the effects of SG and RYGB on liver fat content and fibrosis. Therefore, this study aims to compare the effects of SG and RYGB on hepatic steatosis and fibrosis over a one-year period.
For more information check out the below:
Bariatric Surgery Helps Reduce Hepatic Steatosis In Type 2 Diabetes Patients
Speakers
Dr. Nandita Mohan
BDS, MDS( Pedodontics and Preventive Dentistry)